Imunopharm Technology Co., Ltd.
PrivateLast Round
Series E
Jan 8, 2025
Est. Valuation
$517.17M
Total Funding Raised
$97.1M
Company Overview
Imunopharm Technology Co., Ltd. is a biopharmaceutical company that develops innovative cell and gene therapies to treat serious diseases such as cancer and autoimmune disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imunopharm Technology Co., Ltd. Comparables
Compare Imunopharm Technology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hrain Biotechnology Co., Ltd. | 91% | |
| Juventas Cell Therapy Ltd. | 87% | |
| IASO Bio | 84% |
Imunopharm Technology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Jan 8, 2025 | ||||
| Series D Extension | Oct 31, 2022 | ||||
| Series D | Nov 24, 2021 | ||||
| Series C Extension | Dec 22, 2020 | ||||
| Series C Extension | Oct 19, 2020 | ||||
Series C | Jan 22, 2019 |
Imunopharm Technology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thiel Capital | Series B, Series A |
| Legend Capital | Series B |
| Beijing Zhongguancun Science City Innovation Development Co., Ltd. | Series D Extension |
| China Taiping Insurance Group | Series E |
| 北京首都科技发展集团有限公司 | Series E, Series A |
| SDIC Venture Capital | Series E, Series D, Series C Extension |
| 太平医疗健康基金 | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 26, 2025
Monthly visitors increased 52% MoM, from 355 to 539.
- Oct 1, 2024
Grew 29% QoQ, from 14 to 18 employees.
Imunopharm Technology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Imunopharm Technology Co., Ltd.'s valuation, stock price, and market status.
Is Imunopharm Technology Co., Ltd. a public or private company?
Imunopharm Technology Co., Ltd. is a private company.
What is the current stock price of Imunopharm Technology Co., Ltd.?
Imunopharm Technology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Imunopharm Technology Co., Ltd. worth (valuation)?
Valuation information for Imunopharm Technology Co., Ltd. is not publicly available.
Can I buy Imunopharm Technology Co., Ltd. stock?
Imunopharm Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Imunopharm Technology Co., Ltd.'s last funding round?
Funding round information for Imunopharm Technology Co., Ltd. is not publicly available.
Who are the main investors in Imunopharm Technology Co., Ltd.?
Investor information for Imunopharm Technology Co., Ltd. is not publicly disclosed.
Will Imunopharm Technology Co., Ltd. IPO soon?
No public IPO plans have been announced for Imunopharm Technology Co., Ltd..
How can I track Imunopharm Technology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Imunopharm Technology Co., Ltd.'s secondary market activity and sign up for updates.